AKT-IN-17
Product Specifications
UNSPSC Description
AKT-IN-17 is a AKt inhibitor. AKT-IN-17 inhibits AKt in A549 cells, leading to Apoptosis. AKT-IN-17 is a potential anti-NSCLC agents, can be used in non-small cell lung cancer study[1].
Target Antigen
Akt
Type
Reference compound
Related Pathways
PI3K/Akt/mTOR
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/akt-in-17.html
Solubility
10 mM in DMSO
Smiles
O=C(N/N=C/C1=CC=C(N2CCCCC2)C=C1)CSC3=NC4=CC(Cl)=CC=C4O3
Molecular Weight
428.94
References & Citations
[1]Erdönmez B, et al. Design, Synthesis, and Evaluation of a New Series of Hydrazones as Small-Molecule Akt Inhibitors for NSCLC Therapy. ACS Omega. 2023 May 24;8(22):20056-20065.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-149841/AKT-IN-17-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-149841/
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Rabbit Polyclonal NKX6.1 Antibody [DyLight 350]](https://cdn.genprice.uk/genprice/genprice5.png)
